Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International Study Using Clopidogrel and Aspirin for Polycythemia Vera
2007-007801-63Phase 3Completed
- Sponsor
- Policlinico Gemelli
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clopidogrel in polycythemia vera (PV), sponsored by Policlinico Gemelli. Primary endpoints: Reduction in leukocyte activation and Effect of CYP2C19 loss-of-function polymorphism. Started Nov 2008; status: completed.
02
Drugs
clopidogrel
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on 2007-007801-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007801-63.